| Literature DB >> 27443594 |
Matthias Vossen1, Dieter Mitteregger2, Christoph Steininger3.
Abstract
Neisseria meningitidis remains the most important cause of bacterial meningitis worldwide, particularly in children and young adults. The second most common and a potentially severe end-organ manifestation of invasive meningococcal disease (excluding systemic sepsis) is meningococcal pneumonia. It occurs in between 5% and 15% of all patients with invasive meningococcal disease and is thus the second most common non-systemic end-organ manifestation. To establish the diagnosis requires a high level of clinical awareness - the incidence is therefore very likely underreported and underestimated. This review of 344 meningococcal pneumonia cases reported in the Americas, Europe, Australia, and Asia between 1906 and 2015 presents risk factors, pathogenesis, clinical manifestations, diagnostic approaches, treatment, and prognosis of meningococcal pneumonia.Entities:
Keywords: Invasive meningococcal disease; Neisseria meningitidis; Pneumonia
Mesh:
Year: 2016 PMID: 27443594 DOI: 10.1016/j.vaccine.2016.07.013
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641